Published 7 days ago • loading... • Updated 7 days ago

AbbVie and BioLabs University of Toronto Accept Applications for the AbbVie Award for Biotechnology Innovators at the Life Sciences Ontario Forum

AbbVie and BioLabs University of Toronto collaborate to support the next generation of biotechnology innovators in Ontario.Two companies

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

Les Affaires

AbbVie and BioLabs University of Toronto Accept Applications for the AbbVie Award for Biotechnology Innovators at the Life Sciences Ontario Forum

AbbVie and BioLabs University of Toronto collaborate to support the next generation of biotechnology innovators in Ontario.Two companies

7 days ago·Montreal, Canada

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left0Leaning Right0Center0Last Updated7 days agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Les Affaires broke the news in Montreal, Canada 7 days ago on Tuesday, September 15, 2026.

Sources are mostly out of (0)

AbbVie and BioLabs University of Toronto Accept Applications for the AbbVie Award for Biotechnology Innovators at the Life Sciences Ontario Forum

1 Articles

1 Articles

AbbVie and BioLabs University of Toronto Accept Applications for the AbbVie Award for Biotechnology Innovators at the Life Sciences Ontario Forum

Coverage Details

Bias Distribution

Factuality

Ownership

More stories like this

Health: Vitiligo and Alopecia, Experts and Patients 'Are Recognized by Ssn for Access to New Therapies'

Medications: Vitiligo and Alopecia, Cordella (AbbVie) Are Committed to Improving Standards of Care Also

ADARx Pharmaceuticals targets $1.74 billion valuation in US IPO

Suspect in shooting outside Belleville, Ont. synagogue has died

DoorDash to Pay $131M for Underpaying Delivery Workers in New York City

Pickering nuclear reactors start coming off-line for massive refurbishment

Similar News Topics

Similar News Topics

More stories like this

Health: Vitiligo and Alopecia, Experts and Patients 'Are Recognized by Ssn for Access to New Therapies'

Medications: Vitiligo and Alopecia, Cordella (AbbVie) Are Committed to Improving Standards of Care Also

ADARx Pharmaceuticals targets $1.74 billion valuation in US IPO

Suspect in shooting outside Belleville, Ont. synagogue has died

DoorDash to Pay $131M for Underpaying Delivery Workers in New York City

Pickering nuclear reactors start coming off-line for massive refurbishment

AbbVie and BioLabs University of Toronto Accept Applications for the AbbVie Award for Biotechnology Innovators at the Life Sciences Ontario Forum

1 Articles

1 Articles

Translate IconAbbVie and BioLabs University of Toronto Accept Applications for the AbbVie Award for Biotechnology Innovators at the Life Sciences Ontario Forum

Coverage Details

Bias Distribution Too Big Arrow Icon

Factuality Info Icon

Ownership

More stories like this

Health: Vitiligo and Alopecia, Experts and Patients 'Are Recognized by Ssn for Access to New Therapies'

Medications: Vitiligo and Alopecia, Cordella (AbbVie) Are Committed to Improving Standards of Care Also

ADARx Pharmaceuticals targets $1.74 billion valuation in US IPO

Suspect in shooting outside Belleville, Ont. synagogue has died

DoorDash to Pay $131M for Underpaying Delivery Workers in New York City

Pickering nuclear reactors start coming off-line for massive refurbishment

Similar News Topics

Similar News Topics

More stories like this

Health: Vitiligo and Alopecia, Experts and Patients 'Are Recognized by Ssn for Access to New Therapies'

Medications: Vitiligo and Alopecia, Cordella (AbbVie) Are Committed to Improving Standards of Care Also

ADARx Pharmaceuticals targets $1.74 billion valuation in US IPO

Suspect in shooting outside Belleville, Ont. synagogue has died

DoorDash to Pay $131M for Underpaying Delivery Workers in New York City

Pickering nuclear reactors start coming off-line for massive refurbishment

AbbVie and BioLabs University of Toronto Accept Applications for the AbbVie Award for Biotechnology Innovators at the Life Sciences Ontario Forum

Bias Distribution

Factuality